CJC 1295 (without DAC) + Ipamorelin Blend
Batch-specific COA documentation is available where applicable via the QR code on the vial label or through our COA Verification page.
Please use the product name and batch/lot number shown on the vial label to locate the relevant documentation.
For research purposes only.
Mechanistic focus
- Investigated in combined pathways relating to growth hormone signalling
- Explored for complementary receptor interaction and signalling modulation
- Studied for its role in endocrine system response mechanisms
Study areas
- Combined peptide signalling models
- Hormone pathway interaction systems
- Endocrine regulation research
Composition
- CJC-1295 (without DAC) — 5mg
- Ipamorelin — 5mg
Total: 10mg
DAC note
This blend contains the non-DAC form of CJC-1295, commonly referenced in research involving shorter peptide activity profiles.
Compound Pairing Rationale
- Combined to explore synergistic growth hormone signalling pathways
- Investigated for interaction between receptor activation and signalling modulation
- Selected for research involving coordinated endocrine response models
Presentation
Lyophilised powder in vial.
Batch Documentation
Batch-specific COAs are available where applicable.
Independent third-party analysis is provided by Janoshik Analytical, where applicable. COAs can be viewed via the on-label QR code or COA verification page.
Handling & Storage
Handled and stored under controlled conditions to maintain consistency in presentation and documentation.
Important Notice
For research purposes only. Not for human consumption.
Choose options
product verification
Independent analysis supporting batch authenticity and purity.
Controlled handling
Handled and stored under controlled laboratory conditions.
UK despatch
Discreet, secure, and reliable delivery from within the UK.